Integral Molecular Announces Preclinical P2X7 Antibody Assets for Autoimmune Disorders
PHILADELPHIA – Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces lead monoclonal antibodies (MAbs) against P2X7, a structurally complex ion […]